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Abstract
Purpose: Mirizzi syndrome is a rare complication of long standing cholelithiasis. The purpose of
this study is to retrospectively estimate the diagnostic and treatment methods applied in patients
with Mirizzi syndrome.
Materials and methods: Our experience with 27 cases with Mirizzi syndrome is presented. They
were diagnosed either by imaging techniques, or during surgical operation. All of the patients were
managed surgically.
Results: 8 patients were diagnosed preoperatively and the rest intraoperatively. Morbidity rate
after surgery was 18,5%, and mortality rate was zero. The patients presented free of symptoms
three months after surgery during the follow-up.
Conclusion: Mirizzi syndrome is rarely diagnosed preoperatively and US proved inadequate for
this purpose. Surgery is the only therapy and usually provides additionally definitive diagnosis.
Introduction
Mirizzi syndrome is an unusual complication of gallstone
disease and occurs in approximately 1% of all patients
with cholelithiasis [1]. The syndrome was first described
in 1948 and is characterized by impaction of stones in the
cystic duct or neck of the gallbladder, resulting in mechan-
ical obstruction of the common hepatic duct and frequent
clinical presentation of intermittent or constant jaundice
[2]. The majority of cases are not identified preopera-
tively, despite the availability of modern imaging tech-
niques.
Thus a constant vigilance during intraoperative dissection
of Calot's triangle is required in order to avoid injury of
the bile duct.
Patients-methods and results
This is a retrospective study of 27 consecutive patients
with Mirizzi syndrome in the last 20 years (1986–2005),
treated at the 2nd Department of Propaedeutic Surgery,
Medical School, University of Athens. A total of 2,978
cholecystectomies were performed during this period.
Among the 27 patients with Mirizzi syndrome, 21 patients
(77,7%) had type I disease, 5 patients (18,5%) had type II
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records of these 27 patients were reviewed for clinical
symptoms, diagnostic methods, surgical procedures, com-
plications and follow-up. The Csendes classification was
followed to categorize the patients. For types II, III or IV
when cholecystobiliary fistula existed, the classification
was made intraoperatively. All patients were seen in the
surgical department within 3 months from their discharge
from the hospital and every 6 months thereafter for a
mean period of five years (range: 3–13 years). Four
patients were lost from follow-up 1–2 years after surgery.
All were symptom free with normal liver function tests
through the last follow-up visit. None of the patients with
Mirizzi syndrome had previous hepatobiliary surgical
intervention prior to diagnosis. Females outnumbered
males by sixteen to eleven. The age of patients ranged
from 48 years to 86 years. Upper abdominal pain, fever
and jaundice were the most frequent symptoms and signs.
The diagnosis of Mirizzi syndrome was achieved preoper-
atively in 8 patients (29,6%). The other 19 patients
(70,3%) were diagnosed intraoperatively. For preopera-
tive evaluation of the patients the technological advance-
ments of the last three decades were employed.
Despite arguments in the literature about the usefulness
of ultrasonography (US) in diagnosis, it proved to be of
limited value, as in only 8 patients was US indicative for
Mirizzi syndrome. In these 8 cases, the diagnosis was con-
firmed by endoscopic retrograde cholangiopancreatogra-
phy (ERCP) in 6 cases, while by magnetic resonance
cholangiopancreatography (MRCP) and percutaneus
cholangiography (PC) the remaining two cases. The diag-
nostic value of the employed non-invasive imaging tech-
niques in our series is shown in table 1. In our series
dilated hepatic radicals were observed in 13 patients. One
case of cholecystocholedochal fistula was identified in the
preoperative work-up. All of the patients were operated on
using, either a right subcostal incision (20 cases), or right
paramedian incision (6 cases).
Surgical treatment was applied in all patients with Mirizzi
syndrome. In 21 patients with type I disease, partial chole-
cystectomy was performed in 15 cases and complete
cholecystectomy in 6 cases. In 4 cases laparoscopic chole-
cystectomy was attempted but only in one case it was
achieved. Among the six patients with cholecystobiliary
fistula, in five patients with type II disease T-tube insertion
from the fistula or directly to the common bile duct using
the gallbladder as a pedicled graft in either case was per-
formed.
In the remaining patient with type II or III disease with a
particular appearance of the fistula opening after extrac-
tion of the gallstone (photo) and considering the risk of
postoperative biliary stricture increased, a Roux-en-Y
cholecysto-choledochal-jejunostomy was carried out (Fig.
1). No bile leak was noted in any patient with cholecysto-
biliary fistula, whereas bile leakage was noted in 3 patients
treated by partial cholecystectomy. Spontaneous stop of
leaking was observed in both cases after 4 and 6 days
respectively. In the remaining case biliary stenting on the
10th postoperative day was necessary. All patients had a
tube drain left in the subhepatic space that remained for 2
to 15 days. Furthermore, two patients developed wound
infection necessitating open drainage. Overall morbidity
was 18,5% (5 cases). The mortality rate in our series was
zero. Histology did not reveal concomitant carcinoma of
the gallbladder in any of the patients.
Discussion
Mirizzi syndrome (MS) was described in 1948 as obstruc-
tive jaundice due to gallstone/s impacted in the cystic duct
or Hartmann's pouch, compressing the common hepatic
duct2. McSherry in 1982 suggested a subclassification of
the Mirizzi syndrome into two types.
Type I regards the external compression of the common
hepatic by a calculus in the cystic duct or Hartmann's
pouch whereas, in type II the stone has eroded partially or
completely into the common hepatic bile duct and a
cholecystocholedochal fistula has resulted [3].
In 1989 a new classification of patients with Mirizzi syn-
drome and cholecystobiliary fistula was presented. Type I
lesions are those with external compression of the com-
mon bile duct; in type II lesions a cholecystobiliary fistula
is present with erosion of less than one third of the cir-
cumference of the bile duct; in type III lesions, the fistula
involves up to two thirds of the duct circumference; and
in type IV there is complete destruction of the bile duct
[4].
Therefore, Mirizzi syndrome and cholecystobiliary fistula
appear to be different, evolving stages of the same patho-
logical condition; thus, it is reasonable that Lubbers pro-
poses that the term Mirizzi syndrome could not be
abandoned, as it is only the first stage of a more complete
process [5].
Nevertheless, gallstone erosion into the common duct is a
rare complication of cholelithiasis and is mainly the result
Table 1: Diagnostic value of the non invasive imaging techniques 
used in our patients with Mirizzi Syndrome.
TECHNIQUE N° PATIENTS DIAGNOSTIC %
US 27 8 29.6
CT SCAN 6 0 0
ERCP 11 6 54.5
MRCP 2 1 50Page 2 of 4
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holedochal fistula is an important complication of Mirizzi
syndrome but it occurs only in 1% of all biliary operations
[1,4]. Clinical diagnosis of Mirizzi syndrome is difficult,
since there are no pathognomonic patterns in presenta-
tion. Blood investigations are not very helpful. Diagnosti-
cally, ultrasound is the first screening method but may
miss the presence of Mirizzi syndrome, as CT can also do.
ERCP is able to confirm the diagnosis in 50% of cases.
MRCP can be as good as ERCP in diagnosis and its ability
to delineate details of biliary strictures, but its disadvan-
tage compared to ERCP is its inability to confirm the pres-
ence of fistula and offer therapeutic stenting [6]. On the
other hand, T2 sections can differentiate a neoplastic mass
from an inflammatory one, which U/S or CT scan may not
be capable of doing.
The association of Mirizzi syndrome and gallbladder car-
cinoma is also of interest; in such cases it is obvious that
complex surgical procedures should be avoided [7,8].
However, despite all these modern diagnostic modalities,
it is possible for the problem to become apparent only
during operation [9]. Intraoperatively, the presence of
Mirizzi syndrome can be suggested by the finding of
intense adhesions between the gallbladder and the com-
mon hepatic duct in the area of Calot's triangle [10].
In fact, surgery is the treatment of choice for patients with
diagnosis of Mirizzi syndrome. The surgical strategy
includes complete removal of the gallbladder or partial
cholecystectomy for MS type I, while various surgical
approaches have been used for MS type II, where chole-
cystobiliary fistula is present and requires treatment.
The following approach is rather more accepted for type
II. After the gallstone has been removed and partial chole-
cystectomy has been performed, the remaining gallblad-
der is used for choledochoplasty. A T-tube is introduced
into the common hepatic duct above the repair site. Fur-
thermore, in our department, in order to close the hole in
the common bile duct, we have used, besides the gallblad-
der cuff, a pedicled graft of the round ligament of the liver
[11,12]. Recently we have performed a Roux-en-Y chole-
cysto-choledochal-jejunostomy with favorable outcome
in a patient with MS type II/III based on operative findings
[13].
In our opinion, an 8–15 mm cuff of the gallbladder or
round ligament is sufficient in order to close the defect in
the common bile duct.
The role of laparoscopic approach in the treatment of Mir-
izzi syndrome remains controversial. Some authors con-
sider the condition unsuitable for laparoscopic surgery
Schematic representation of the cholecysto-choledochal jejunostomyFigure 1
Schematic representation of the cholecysto-choledochal jejunostomy.Page 3 of 4
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since the inflammatory tissue in the area of Calot's trian-
gle offers a high operative risk in dissection [6,14,15].
Other authors propose laparoscopic surgery in the treat-
ment of Mirizzi syndrome [16-18]. We consider that in
presence of cholecystocholedochal fistula conventional
laparotomy is mandatory. Even in type I Mirizzi syn-
drome, laparoscopic surgery is not always feasible. Thus,
in our series three operations with initial access by lapar-
oscopy were converted to laparotomy due to major tech-
nical difficulties.
In high-risk patients suffering from MS, biliary drainage
by endoscopic sphincterotomy and placement of a stent
in the choledochal duct has been carried out [19]. Moreo-
ver placement of a nasobiliary catheter in conjunction
with cholangioscopy for electrohydraulic lithotripsy has
been reported [20,21].
Although the diagnostic imaging techniques have been
perfected, preoperative diagnosis of MS is not an easy
affair and continues to be a challenge for the surgeon.
Therefore, even intraoperative precautious recognition of
the condition and application of the appropriate surgical
method according to the characteristics of each case will
lead to successful treatment. In conclusion, it is important
to identify patients with Mirizzi syndrome preoperatively
but it seems even more important to consider its diagnosis
during surgical dissection.
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